Carcinoma of the prostate: local control with external beam radiation therapy.
Local clinical control of the primary disease was evaluated in 209 patients with stage C adenocarcinoma of the prostate treated with definitive external beam radiation therapy and followed for a minimum of 2 years. Of these patients 92 per cent required no further prostatic operations for obstruction. Prostatectomy before therapy did not necessarily prevent later prostatic obstruction from occurring. Of 129 patients who had only a needle biopsy before irradiation 90 per cent had improvement of the obstructive and/or irritative symptoms as tumor regression occurred with therapy and these patients did not require a later prostatic operation for obstruction. Stricture formation occurred in 8 per cent of the patients and was not influenced by the type of preirradiation prostatic operation done. If transurethral resection was reuqired after irradiation it was technically more difficult but the morbidity was acceptable. The incidence of hematuria and incontinence was far less than that reported in non-irradiated patients with this disease. Most tumors exhibited a down-grading effect after irradiation. There were no deaths attributable to the treatment. Over-all, 83 per cent of the 209 patients had no urinary complaints after completion of therapy. From a urological viewpoint, good clinical local control is achieved in the patient with stage C adenocarcinoma of the prostate treated with external beam radiation therapy.
D000230:Adenocarcinoma / Q000532:radiotherapy*; D000368:Aged; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000150:complications / Q000532:radiotherapy* / Q000601:surgery; D011867:Radioisotope Teletherapy; D011878:Radiotherapy / Q000009:adverse effects; D011882:Radiotherapy, High-Energy; D014525:Urethral Stricture / Q000209:etiology; D001748:Urinary Bladder Neck Obstruction / Q000209:etiology
D003037:Cobalt Radioisotopes